drugset
Drugs / LMI
last change Jul 2014 re-read 3 minutes ago

LMI

Vaccine

Developed for
breast cancer
Investigated by
Masonic Cancer Center, University of Minnesota

Trials 1

today NCT00784524 · Ph 2
2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00784524 Sep 2008 → Jul 2014 breast cancer Masonic Cancer Center, University of Minnesota Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LMI “allogeneic large multivalent immunogen (LMI) vaccine” NCT00784524 ↗
Modality Vaccine “allogeneic large multivalent immunogen (LMI) vaccine” NCT00784524 ↗